Literature DB >> 4243

Purification and properties of human acid-thermostable ribonucleases, and diagnosis of childhood pancreatic fibrosis.

A Bardoń, H Slerakowska, D Shugar.   

Abstract

Acid-thermostable ribonucleases were isolated from human pancreas, duodenal contents, liver, spleen, serum and urine, and purified 15--1000-fold. The pH optima, ionic requirements, and some of the specificity requirements, of these enzymes were investigated. The isolated enzymes formed two distinct groups: (a) The ribonucleases of the pancreas, duodenal contents and fraction A of serum and urine exhibit a pH optimum of 8.5, are inhibited by An2+ and Cu2+, and relatively rapidly hydrolyze the synthetic substrate uridine 3'-(alpha-naphthylphosphate); (b) the ribonucleases of the liver and spleen, and of fractions B of the serum and urine, with a pH optimum of 7, are less sensitive to An2+ and Cu2+, and exhibit negligible activity versus uridine 3'-(alpha-naphthylphosphate). Determination of the serum level of pancreatic-type ribonuclease activity, with the use of uridine 3'-(alpha-naphthylphosphate) or RNA as substrates, appears to be a valid diagnostic tool for pancreatic fibrosis in children.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4243     DOI: 10.1016/0009-8981(76)90331-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Activity of two components of serum ribonuclease under conditions of physical exercise.

Authors:  A Szczesna-Kaczmarek
Journal:  Experientia       Date:  1976-12-15

2.  Genetic polymorphism of human serum ribonuclease I (RNase I).

Authors:  T Yasuda; W Sato; K Mizuta; K Kishi
Journal:  Am J Hum Genet       Date:  1988-04       Impact factor: 11.025

3.  The immunological characterization of several human ribonucleases by using primary binding tests.

Authors:  E A Neuwelt; M Schmukler; M S Niziak; P B Jewett; C C Levy
Journal:  Biochem J       Date:  1977-06-01       Impact factor: 3.857

4.  Site-specific RNase A activity was dramatically reduced in serum from multiple types of cancer patients.

Authors:  Weiyan Huang; Mei Zhao; Na Wei; Xiaoxia Wang; Huqing Cao; Quan Du; Zicai Liang
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.